{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T04:14:17Z","timestamp":1684556057502},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Drug Discov"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/nrd3189","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T09:34:35Z","timestamp":1275384875000},"page":"432-433","source":"Crossref","is-referenced-by-count":1,"title":["New oral HCV drug shows promise"],"prefix":"10.1038","volume":"9","author":[{"given":"Man","family":"Tsuey Tse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrd3189_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nature08960","volume":"465","author":"M Gao","year":"2010","unstructured":"Gao, M. et al. Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature 465, 96\u2013100 (2010)","journal-title":"Nature"},{"key":"BFnrd3189_CR2","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1128\/AAC.49.4.1346-1353.2005","volume":"49","author":"DR O'Boyle II","year":"2005","unstructured":"O'Boyle II, D. R. et al. Development of a cell-based high-throughput specificity screen using a hepatitis C virus\u2013bovine viral diarrhea virus dual replicon assay. Antimicrob. Agents Chemother. 49, 1346\u20131353 (2005)","journal-title":"Antimicrob. Agents Chemother."},{"key":"BFnrd3189_CR3","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1128\/JVI.01360-09","volume":"84","author":"JA Lemm","year":"2010","unstructured":"Lemm, J. A. et al. Identification of hepatitis C virus NS5A inhibitors. J. Virol. 84, 482\u2013491 (2010)","journal-title":"J. Virol."}],"container-title":["Nature Reviews Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrd3189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd3189","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrd3189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:04:14Z","timestamp":1684469054000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrd3189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFnrd3189"],"URL":"https:\/\/doi.org\/10.1038\/nrd3189","relation":{},"ISSN":["1474-1776","1474-1784"],"issn-type":[{"value":"1474-1776","type":"print"},{"value":"1474-1784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}